4//SEC Filing
Poole Robert Michael 4
Accession 0001209191-23-013251
CIK 0001636651other
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 5:01 PM ET
Size
5.3 KB
Accession
0001209191-23-013251
Insider Transaction Report
Form 4
Poole Robert Michael
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-02-23+15,000→ 15,000 totalExercise: $2.50Exp: 2033-02-22→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]The option will vest in full on February 23, 2024 subject to the Reporting Person's continuous service through such vesting date.
Documents
Issuer
Ovid Therapeutics Inc.
CIK 0001636651
Entity typeother
Related Parties
1- filerCIK 0001871782
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 5:01 PM ET
- Size
- 5.3 KB